Lifecore Biomedical, Inc. (FRA:LDE)

Lifecore Biomedical Statistics

Total Valuation

FRA:LDE has a market cap or net worth of EUR 255.26 million. The enterprise value is 398.42 million.

Market Cap	255.26M
Enterprise Value	398.42M

Important Dates

The next estimated earnings date is Friday, January 2, 2026.

Earnings Date	Jan 2, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	37.47M
Shares Outstanding	n/a
Shares Change (YoY)	-5.02%
Shares Change (QoQ)	+1.07%
Owned by Insiders (%)	1.95%
Owned by Institutions (%)	29.72%
Float	19.81M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.25
PB Ratio	6.10
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-10.18
EV / Sales	3.58
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-33.15

Financial Position

The company has a current ratio of 2.84, with a Debt / Equity ratio of 2.76.

Current Ratio	2.84
Quick Ratio	1.46
Debt / Equity	2.76
Debt / EBITDA	n/a
Debt / FCF	-9.60
Interest Coverage	-0.55

Financial Efficiency

Return on equity (ROE) is -76.41% and return on invested capital (ROIC) is -4.16%.

Return on Equity (ROE)	-76.41%
Return on Assets (ROA)	-3.04%
Return on Invested Capital (ROIC)	-4.16%
Return on Capital Employed (ROCE)	-5.74%
Revenue Per Employee	280,048
Profits Per Employee	-96,399
Employee Count	406
Asset Turnover	0.52
Inventory Turnover	2.45

Taxes

In the past 12 months, FRA:LDE has paid 37,939 in taxes.

Income Tax	37,939
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -4.32% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-4.32%
50-Day Moving Average	6.07
200-Day Moving Average	6.05
Relative Strength Index (RSI)	58.33
Average Volume (20 Days)	189

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	15.24

Income Statement

In the last 12 months, FRA:LDE had revenue of EUR 113.70 million and -39.14 million in losses. Loss per share was -1.12.

Revenue	113.70M
Gross Profit	35.55M
Operating Income	-10.59M
Pretax Income	-34.12M
Net Income	-39.14M
EBITDA	-3.51M
EBIT	-10.59M
Loss Per Share	-1.12

Balance Sheet

The company has 7.29 million in cash and 115.43 million in debt, giving a net cash position of -108.13 million.

Cash & Cash Equivalents	7.29M
Total Debt	115.43M
Net Cash	-108.13M
Net Cash Per Share	n/a
Equity (Book Value)	41.85M
Book Value Per Share	0.03
Working Capital	48.97M

Cash Flow

In the last 12 months, operating cash flow was -181,754 and capital expenditures -11.84 million, giving a free cash flow of -12.02 million.

Operating Cash Flow	-181,754
Capital Expenditures	-11.84M
Free Cash Flow	-12.02M
FCF Per Share	n/a

Margins

Gross margin is 31.27%, with operating and profit margins of -9.32% and -30.04%.

Gross Margin	31.27%
Operating Margin	-9.32%
Pretax Margin	-30.01%
Profit Margin	-30.04%
EBITDA Margin	-3.09%
EBIT Margin	-9.32%
FCF Margin	n/a

Dividends & Yields

FRA:LDE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	5.02%
Shareholder Yield	5.02%
Earnings Yield	-15.33%
FCF Yield	-4.71%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:LDE has an Altman Z-Score of 0.1 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.1
Piotroski F-Score	3